🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Shenzhen Ionova Life Sciences clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China and USA registers with Shenzhen Ionova Life Sciences as lead sponsor. Synced 26 Sep 2026
4Current trials
4Recruiting now
0Drugs in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Shenzhen Ionova Life Sciences is the lead sponsor of 4 current clinical trials in our China and USA registers. 4 are recruiting patients now. The most common phase is Phase 1/2. The most-studied condition is Cancer.

ClinicalTrials.gov trials by status

  • Recruiting4100%

Trials by phase

  • Phase 1/2375%
  • Phase 1125%
01

Clinical trials sponsored by Shenzhen Ionova Life Sciences

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
NCT04443088 · Cancer, Solid Tumor, Adult, Cancer Metastatic
Phase 1 Recruiting 2020-06 USA
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
NCT06609005 · ClinicalTrials.gov ↗ · Advanced Metastatic Castration Resistant Prostate Cancer
Phase 1/2 Recruiting 2025-01 USA, China
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
NCT07610798 · ClinicalTrials.gov ↗ · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
Phase 1/2 Recruiting 2026-06 China
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
NCT07612891 · ClinicalTrials.gov ↗ · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer
Phase 1/2 Recruiting 2025-07 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Shenzhen Ionova Life Sciences trials

13 conditions
Cancer1Solid Tumor, Adult1Cancer Metastatic1Solid Carcinoma1Advanced Metastatic Castration Resistant Prostate Cancer1Advance Solid Tumors1Colon and Rectal Cancer1Non - Small Cell Lung Cancer NSCLC1Pancreatic Adenocarcinoma Advanced or Metastatic1Breast Cancer (Locally Advanced or Metastatic)1Advanced Solid Cancers1Metastatic (Stage IV) Breast Cancer1Ovarian Cancer1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China33
Clinical trials in USA22

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Cancer

SponsorTrials
GRAIL4
Peking University Cancer Hospital & Institute4
Our Lady's Hospice and Care Services3
Conjupro Biotherapeutics3
University of Dublin, Trinity College2
Replimune2
Tempus AI2
Elephas2
First Hospital of China Medical University2
Qinghai Red Cross Hospital2

Sponsors with the most current trials registered for this condition.

05

Questions about Shenzhen Ionova Life Sciences trials

How many clinical trials does Shenzhen Ionova Life Sciences sponsor?

Shenzhen Ionova Life Sciences is the lead sponsor of 4 current trials on ClinicalTrials.gov in our China and USA registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Shenzhen Ionova Life Sciences trials recruiting?

Yes. 4 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.